Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
6.69M
-
Shares change
-
-352
-
Total reported value, excl. options
-
$43.3M
-
Value change
-
-$2.61K
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$6.47
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2021
15 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q3 2021.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.69M shares
of 71.9M outstanding shares and own 9.31% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (5.9M shares), Neumann Advisory Hong Kong Ltd (316K shares), STATE STREET CORP (282K shares), Yorktown Management & Research Co Inc (74.9K shares), Skandinaviska Enskilda Banken AB (publ) (40K shares), GEODE CAPITAL MANAGEMENT, LLC (27.7K shares), Eqis Capital Management, Inc. (17.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16.6K shares), UBS Group AG (9.1K shares), and MORGAN STANLEY (3.84K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.